Suppr超能文献

小鼠半同种异体骨髓移植后的白细胞介素2调节

Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.

作者信息

Abdul-Hai Ali, Ben-Yehuda Arie, Galsky Haya, Slavin Shimon, Or Reuven

机构信息

Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, 91120 Jerusalem, Israel.

出版信息

Cancer Immunol Immunother. 2006 Nov;55(11):1330-6. doi: 10.1007/s00262-006-0125-y. Epub 2006 Feb 1.

Abstract

Success of allogeneic and autologous bone marrow transplantation (BMT) is hampered by susceptibility to infection during the first two post-treatment years. Further, in treating malignant diseases, impaired anti-host reactivity for donor cells may contribute to a high rate of relapse. Both complications are a consequence of immune deficiency involving B and T lymphocytes. The present study evaluates several key parameters of the immunologic reconstitution mechanism in mice subjected to myeloablative total body irradiation following semi-allogeneic (parental) BMT. This resulted in a gradual reduction of splenic CD3, CD4 and CD8 cells until day 45 post-BMT. Concomitantly, there was an increase in monocytes and CD4+/CD8+ (double positive) cells, accompanied by a persistent elevation in the percentage of B lymphocytes. The total thymic and splenic T cell populations were reduced until day +30. The cellular reduction correlated with the poor proliferative response of the thymic and splenic cells. A decrease occurred in IL-2 mRNA expression in thymic cells during days 15-20 post-transplant, corresponding with the low level of IL-2 secretion in the spleen and thymus of the transplanted mice. In conclusion, following semi-allogeneic BMT, there was an overall immune down-regulation in the cells, gene and protein levels. Reduced immunological responsiveness following BMT reinforces the need for improving the immune dysfunction by immunotherapy post-BMT.

摘要

异基因和自体骨髓移植(BMT)的成功受到治疗后前两年易感染的阻碍。此外,在治疗恶性疾病时,供体细胞的抗宿主反应受损可能导致高复发率。这两种并发症都是涉及B和T淋巴细胞的免疫缺陷的结果。本研究评估了半同种异体(亲代)BMT后接受骨髓清除性全身照射的小鼠免疫重建机制的几个关键参数。这导致脾脏CD3、CD4和CD8细胞逐渐减少,直至BMT后第45天。与此同时,单核细胞和CD4+/CD8+(双阳性)细胞增加,同时B淋巴细胞百分比持续升高。胸腺和脾脏的总T细胞群体减少,直至第+30天。细胞减少与胸腺和脾脏细胞的增殖反应不佳相关。移植后第15 - 20天,胸腺细胞中IL - 2 mRNA表达下降,这与移植小鼠脾脏和胸腺中IL - 2分泌水平低相对应。总之,半同种异体BMT后,细胞、基因和蛋白质水平总体上存在免疫下调。BMT后免疫反应性降低强化了通过BMT后免疫疗法改善免疫功能障碍的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验